Archive for April 11th, 2012

Study: Diabetes may raise tuberculosis risk

Diabetes elevates the risk of contracting tuberculosis by up to threefold, according to a study presented at the 22nd European Congress of Clinical Microbiology and Infectious Diseases. Researcher Dr. Antonio Moreno said health care providers should increase their awareness and "level of suspicion and screening" among patients with diabetes or TB.

Endocrine Today


Study: Eating fruits & veggies reduces diabetes risk

A study published in Diabetes Care found a correlation between greater consumption of fruits and vegetables and a lower risk of developing type 2 diabetes. The study, examining 3,704 participants over 11 years, also found that people who ate more vegetables and a greater variety of fruits and vegetables had less risk.

Study: Obesity raises U.S. health care costs by billions

Researchers at Cornell University found the U.S. spends $190.2 billion annually for obesity-related expenditures, or about 21% of national health care costs. The findings were published in the Journal of Health Economics.

Insurance Journal


FDA rejects move to block generic Vancocin

Watson Pharmaceuticals and Akorn will launch generic versions of ViroPharma's antibiotic Vancocin after FDA regulators denied a citizen petition to halt approval. ViroPharma plans to seek an injunction blocking the sale of the generics.



Johnson & Johnson fined for bribing doctors

US authorities fined cosmetics and drugs giant Johnson & Johnson $70 million on Friday for bribing doctors in Europe and paying kickbacks for contracts under a UN relief program in Iraq.

Agence France-Presse


Jury rules against Johnson & Johnson subsidiary in Arkansas
A Johnson & Johnson subsidiary downplayed and hid risks associated with the antipsychotic drug Risperdal, a jury determined Tuesday in Arkansas' billion-dollar lawsuit against Janssen Pharmaceuticals Inc … Arkansas' lawsuit was one of dozens of state and federal cases accusing Janssen of fraud connected with Risperdal. In January, Janssen settled with Texas for $158 million in a similar suit. Texas sought damages of about $1 billion.

Greed in Drug Development vs. Quality of Life

The U.S. is outspending all other countries on healthcare, some $2.5 trillion in 2009. The silver lining: cancer patients in the U.S. live an average of 11 years compared with nine years in European countries. “While that sounds like good news, what I’m afraid of is that drug companies are going to read this data and see dollar signs in developing new cancer drugs that merely extend life for a short time rather than focusing on treatments that really put this horrible disease in remission,” blogger Rich Meyer writes. Although patients are living longer, their quality of life isn’t up to par. “There are far too many cancer ‘treatments’ that sell hope rather than a better quality of life and that needs to be balanced with the patient needs and wants,” he adds.

Next Big Thing: Aspirin to Cut Cancer Risk

Recent evidence suggests it will not be long before low-dose aspirin is included in recommendations for preventing cancer, researchers argued.

Even a 10% reduction in the rate of all cancers within the first 10 years of treatment could make the risk-benefit ratio favorable to aspirin in people with average risk, according to Michael Thun, MD, of the American Cancer Society in Atlanta, and colleagues.


For the Elderly, Emergency Rooms of Their Own

Mount Sinai Hospital in Manhattan has joined a number of medical centers around the country in creating a special emergency room for geriatric patients.



FDA Warns of Clot Risk with Yaz, Other OCs

Labels for oral contraceptives that contain drospirenone will now note that studies have shown up to a threefold increased risk of blood clots compared with other birth control pills.

MedPage Today


Cats, Dogs & Kids

Scientists are bringing rigor to the study of the emotional and psychological effects of pet ownership on children.



“Dead” Is Real in Tax Deadline

The deadline to file income tax returns — April 17 this year — could be, quite literally, a life-and-death situation for many taxpayers, according to a study of fatal tax-day vehicular accidents.

Nationwide since 1980, more than 400 additional vehicular fatalities occurred on Tax Day, as compared with two control days 1 week before and 1 week after. The difference translated into three excess deaths per Tax Day, investigators reported in a research letter in the April 11 issue of JAMA.


Biologic Fails in Kidney Disorder

The addition of rituximab to a standard immunosuppressive regimen did not increase the overall response rate among patients with lupus nephritis, a randomized trial found.

MedPage Today


Rituximab Side Effects —
April 2012
« Mar   May »